Abstract: Particles, compositions, and methods that aid particle transport in mucus are provided. The particles, compositions, and methods may be used, in some instances, for ophthalmic and/or other applications. In some embodiments, the compositions and methods may involve modifying the surface coatings of particles, such as particles of pharmaceutical agents that have a low aqueous solubility. Such compositions and methods can be used to achieve efficient transport of particles of pharmaceutical agents though mucus barriers in the body for a wide spectrum of applications, including drug delivery, imaging, and diagnostic applications. In certain embodiments, a pharmaceutical composition including such particles is well-suited for ophthalmic applications, and may be used for delivering pharmaceutical agents to the front of the eye and/or the back of the eye.

Abstract: Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof: wherein R1, R2, R3, R4, R5, R6, Q1, Q2, Y1, and Y2 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention.

Abstract: The present invention relates to polymeric particles comprising a biodegradable polymer, and at least one microorganism in a total concentration of at least 108 CFU/g dry weight that is stable for at least 35 weeks at 30° C. and optionally additional carriers and additives as well as to methods for producing polymeric particles and use thereof.

Abstract: Stable aerosol solution formulations comprising glycopyrronium bromide are useful for administration to patients with COPD and other respiratory conditions.

Abstract: The present invention describes a new technology for the formulation of semiochemicals in wick diffusers particularly effective in controlling the diffusion of semiochemicals over periods of several months regardless of the outside temperature.

Abstract: Compounds of the formula (I) wherein the substituents are as defined in Claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and to the use of the compounds or compositions in agriculture or horticulture for combating, preventing or controlling infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, in particular fungi.

Abstract: The invention relates to biocontrol compositions comprising an entomopathogenic fungus, kits comprising such an entomopathogenic fungus, and methods of using such a fungus and compositions to reduce or kill the population of agricultural, vegetable, or horticultural crop insect pests.

Abstract: The present invention comprises a novel combination and composition for controlling weeds in wheat. The combination comprises a post-emergence phenoxy herbicide such as Quizalofop-p-ethyl (QPE). The novel composition further includes a broadleaf herbicide. When applied to wheat comprising QPE tolerance, surprisingly, the novel composition appears to provide synergy that results in increased wheat yield over and above the yield expected from wheat intolerant of QPE, untreated wheat, or wheat treated with either QPE or a broadleaf herbicide. Despite the fact that QPE is typically used to kill members of the grass family, the present invention successfully employs the novel combination to increase wheat yield.

Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein Q is and A, R1, m, X1, X2, X3, X4, Y1, Y2 and Y3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.

Abstract: Products, systems and methods are disclosed for lowering the concentrations of at least one of preservatives and fibrils in a liquid insulin composition. One method comprises replacing at least a portion of at least one of phenol and m-cresol with at least one of cyclodextrins, cyclodextrin polymers, cyclodextrin beads, and an ion exchange resin.

Abstract: Compositions are provided that include ethoxylated lecithin for use as an adjuvant in aqueous composition. Specifically, the compositions may be utilized primarily as drift reduction agents in agricultural compositions, as a soil or foliage penetrant, as a pesticide adjuvant, as a pesticide formulation component, and for other uses. More specifically, the compositions are useful in reducing drift in spray compositions, such as in use in agricultural applications, such as pesticide, herbicide, fungicide and insecticide formulations, in industrial vegetation management (“IVM”) and integrated pest management (“IPM”) applications, in rights-of-way applications, in forestry applications, and other like applications.

Abstract: The present invention relates to a handheld vibrating mesh nebuliser for delivery of a medicament to the respiratory system in therapy. The present invention also relates to a supply container for loading the nebuliser with liquid medicament. The present invention also relates to a kit for delivery of a medicament to a respiratory system and a method of loading a vibrating mesh nebuliser with liquid medicament from a supply container. The present invention also relates to compositions for use in a method of treatment of a respiratory disease in a patient by therapy.

Abstract: A method of regulating pain in a patient includes operations of measuring a patient pain level, determining a dose of ethanol which does not trigger alcohol intolerance or intoxication, delivering the dose of ethanol to the patient by inhalation from an active mesh nebulizer at a repeated interval, measuring the pain level of the patient at a monitoring interval, and determining, based on the patient pain level, whether to adjust the ethanol dose. The dose of ethanol is delivered in the form of particles of nebulized liquid having a diameter ranging from about 0.5 ?m to about 5.0 ?m, which are rapidly absorbed into the bloodstream of a patient and delivered to the brain.

Abstract: Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof: wherein R1, R2, R3, R4, R5, R6, Q1, Q2, Y1, and Y2 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention.

Abstract: Provided is a disinfection composition, preparation method therefor and use thereof. The disinfection composition comprises the following raw materials in parts by weight: 2.2-4.8 parts of disinfection essential oil, 3-8 parts of polyethylene glycol hydrogenated castor oil, 0.05-0.5 parts of phytic acid, 0.05-0.5 parts of citric acid, 20-40 parts of a C2-C3 monohydric alcohol, and 45-62.1 parts of water. The disinfection composition of the present invention has significantly improved chemical stability, and still has good disinfection effect after storage for 3 months at 37° C., and has a significantly improved disinfection effect, a shortened action time, and an increased killing log value.

Abstract: A fungicidal composition for the treatment of banana and/or plantain plants is presented, the active ingredient of which is cinnamic aldehyde, combined with terpene alcohols, ethoxylated castor oil, C11-13 alcohols, and calcium alkyl aryl sulfonate solution. The main advantages of the invention described herein are that the composition demonstrates high efficacy against Sigatoka in banana and/or plantain plants, great stability over time, and very low toxicity.

Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.

Abstract: Methods for enhancing the activity of an ion transporter in a cell and/or treating a channelopathy in a subject based on the administration or use of an effective amount of a fenretinide compound (fenretinide, a fenretinide analog, or a pharmaceutically acceptable salt thereof) and/or zinc are described. The methods are useful for restoring or increasing the cell surface expression of an ion transporter such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) that is mutated or defective. The fenretinide compound and/or zinc may be used in combination with ion transporter modulators, e.g., CFTR modulators, to further enhance the cell surface expression and activity of the ion transporter.

Abstract: Compositions are provided which i) consists essentially of a siloxane defoamer and an alkoxylated C4-10 alcohol, ii) are aqueous concentrates comprising composition i), an adjuvant, and an electrolyte, and iii) are aqueous formulations obtainable by diluting compositions ii). Furthermore the use of compositions i) and ii) for in the preparation of agricultural formulations iii) and the use of such formulations iii) to treat a field or plants.

Abstract: Described is an intra-mammary teat sealant and a corresponding method of forming a physical barrier in the teat canal of a non-human animal for prophylactic treatment of mammary disorders during the animal's dry period. The method includes the step of infusing a bismuth-free teat seal formulation into the teat canal of the animal. The method also prevents the formation of black spot defect in dairy products, especially cheddar cheese, made from the milk of animals so treated.